Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print RSS Feed

Breaking News

Related Searches:
January 27, 2011
Sanofi revenues expected to boost 2011 results  Read More »
January 27, 2011
Zyprexa sales begin to slide, but Cymbalta aids growth  Read More »
January 27, 2011
Alcon integration boosts revenue growth  Read More »
January 27, 2011
Plavix sales continue to roll, while Sprycell, Baraclude and Orencia grow  Read More »
January 26, 2011
CMC issues halt HIV combo application  Read More »
January 26, 2011
Expands Phase I resources with India acquisition  Read More »
January 26, 2011
Product revenues rise, offset by drop in Tamiflu royalties  Read More »
January 26, 2011
Pharma revenues up, but 1,900 layoffs ensue.  Read More »
January 26, 2011
Compound Focus unit to handle liquid chem library collection  Read More »
January 25, 2011
Worldwide Pharmaceutical sales were $22.4 billion for the year (-1%).   Read More »
January 25, 2011
U.S. product sales were flat at $2.9 billion in the quarter and included a $65 million unfavorable impact due to U.S. health care reform.  Read More »
January 25, 2011
Amgen has entered into a definitive agreement to acquire BioVex Group, Inc., a privately held biotechnology company headquartered in Woburn, MA.   Read More »
January 25, 2011
John H. Johnson has been named chief executive officer of Savient Pharmaceuticals, Inc., effective January 31, 2011.   Read More »
January 25, 2011
Sanofi-aventis has acquired an exclusive worldwide license to one of Oxford BioTherapeutics’ (OBT) preclinical antibody programs.  Read More »
January 24, 2011
MuDelta to get accelerated review  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On